|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
214 a.a.
|
 |
|
|
|
|
|
|
|
213 a.a.
|
 |
|
|
|
|
|
|
|
11 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Polyspecificity
|
 |
|
Title:
|
 |
Anti-p24 (HIV-1) fab fragment cb41 complexed with an epitope-unrelated peptide
|
|
Structure:
|
 |
Protein (igg2a kappa antibody cb41 (light chain)). Chain: a. Fragment: fab. Protein (igg2a kappa antibody cb41 (heavy chain)). Chain: b. Fragment: fab. Protein (antigen bound peptide). Chain: c. Engineered: yes
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Strain: balb/c. Cell_line: cb 4/1/1/f6 b-cell hybridoma. Synthetic: yes
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
2.75Å
|
R-factor:
|
0.232
|
R-free:
|
0.332
|
|
|
Authors:
|
 |
T.Keitel,A.Kramer,H.Wessner,C.Scholz,J.Schneider-Mergener,W.Hoehne
|
Key ref:
|
 |
T.Keitel
et al.
(1997).
Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity.
Cell,
91,
811-820.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
19-Mar-99
|
Release date:
|
31-Mar-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P01837
(IGKC_MOUSE) -
Immunoglobulin kappa constant from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
107 a.a.
214 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell
91:811-820
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity.
|
|
T.Keitel,
A.Kramer,
H.Wessner,
C.Scholz,
J.Schneider-Mergener,
W.Höhne.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The X-ray crystal structures of an anti-p24 (HIV-1) monoclonal antibody Fab
fragment alone and in complexes with the epitope peptide GATPQDLNTnL (n =
norleucine), an epitope-homologous peptide GATPEDLNQKLAGN, as well as two
unrelated peptides GLYEWGGARITNTD and efslkGpllqwrsG (D-peptide), are presented
to a maximum resolution of 2.6 A. The latter three peptides were identified from
screening synthetic combinatorial peptide libraries. Although all peptides bind
to the same antigen combining site, the nonhomologous peptides adopt different
binding conformations and also form their critical contacts with different
antibody residues. Only small readjustments are observed within the framework of
the Fab fragment upon binding.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Difference Electron Density Map for the
h-pep/CB4-1 ComplexThe difference electron density was computed
with the 2.60 Å resolution structure amplitudes from the
CB4-1/h-pep crystal and with refined model phases from CB4-1.
Density is shown for >3σ.
|
 |
Figure 2.
Figure 2. Superposition of Variable Domains and Overlay of
Complexed Peptides(A) Variable domain superposition. Residues
from conserved β regions of V[L] (4–6, 20–25, 33–38,
45–48, 63–65, 70–74, 86–89, 102–104) were superimposed
to visualize the V[L]/V[H] rearrangements. The Cα framework
atoms are oriented with V[L] at the left. Peptides are omitted.
Uncomplexed CB4-1, black; complexed with e-pep, yellow; h-pep,
red; u-pep, purple; d-pep, green.(B) Peptide overlay.
Superposition of V[L] and V[H] domains was performed as
described in Table 2. Only the peptides are displayed: e-pep,
yellow; h-pep, red; u-pep, purple; d-pep, green (N terminus:
right). For a general overview of the peptides in complex with
CB4-1 Fab, see Figure 4 in [27].
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(1997,
91,
811-820)
copyright 1997.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Kanduc
(2009).
Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects.
|
| |
Expert Opin Biol Ther,
9,
45-53.
|
 |
|
|
|
|
 |
R.Rajamanonmani,
C.Nkenfou,
P.Clancy,
Y.H.Yau,
S.G.Shochat,
S.Sukupolvi-Petty,
W.Schul,
M.S.Diamond,
S.G.Vasudevan,
and
J.Lescar
(2009).
On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes.
|
| |
J Gen Virol,
90,
799-809.
|
 |
|
|
|
|
 |
I.Mandrika,
P.Prusis,
J.Bergström,
S.Yahorava,
and
J.E.Wikberg
(2008).
Improving the affinity of antigens for mutated antibodies by use of statistical molecular design.
|
| |
J Pept Sci,
14,
786-796.
|
 |
|
|
|
|
 |
V.Král,
P.Mader,
R.Collard,
M.Fábry,
M.Horejsí,
P.Rezácová,
M.Kozísek,
J.Závada,
J.Sedlácek,
L.Rulísek,
and
J.Brynda
(2008).
Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations.
|
| |
Proteins,
71,
1275-1287.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.J.Schofield,
A.R.Pope,
V.Clementel,
J.Buckell,
S.D.Chapple,
K.F.Clarke,
J.S.Conquer,
A.M.Crofts,
S.R.Crowther,
M.R.Dyson,
G.Flack,
G.J.Griffin,
Y.Hooks,
W.J.Howat,
A.Kolb-Kokocinski,
S.Kunze,
C.D.Martin,
G.L.Maslen,
J.N.Mitchell,
M.O' Sullivan,
R.L.Perera,
W.Roake,
S.P.Shadbolt,
K.J.Vincent,
A.Warford,
W.E.Wlson,
J.Xie,
J.L.Young,
and
J.McCafferty
(2007).
Application of phage display to high throughput antibody generation and characterisation.
|
| |
Genome Biol,
8,
R254.
|
 |
|
|
|
|
 |
I.Mandrika,
P.Prusis,
S.Yahorava,
K.Tars,
and
J.E.Wikberg
(2007).
QSAR of multiple mutated antibodies.
|
| |
J Mol Recognit,
20,
97.
|
 |
|
|
|
|
 |
K.W.Wucherpfennig,
P.M.Allen,
F.Celada,
I.R.Cohen,
R.De Boer,
K.C.Garcia,
B.Goldstein,
R.Greenspan,
D.Hafler,
P.Hodgkin,
E.S.Huseby,
D.C.Krakauer,
D.Nemazee,
A.S.Perelson,
C.Pinilla,
R.K.Strong,
and
E.E.Sercarz
(2007).
Polyspecificity of T cell and B cell receptor recognition.
|
| |
Semin Immunol,
19,
216-224.
|
 |
|
|
|
|
 |
N.J.Felix,
and
P.M.Allen
(2007).
Specificity of T-cell alloreactivity.
|
| |
Nat Rev Immunol,
7,
942-953.
|
 |
|
|
|
|
 |
P.Scheerer,
A.Kramer,
L.Otte,
M.Seifert,
H.Wessner,
C.Scholz,
N.Krauss,
J.Schneider-Mergener,
and
W.Höhne
(2007).
Structure of an anti-cholera toxin antibody Fab in complex with an epitope-derived D-peptide: a case of polyspecific recognition.
|
| |
J Mol Recognit,
20,
263-274.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Avrameas,
T.Ternynck,
I.A.Tsonis,
and
P.Lymberi
(2007).
Naturally occurring B-cell autoreactivity: a critical overview.
|
| |
J Autoimmun,
29,
213-218.
|
 |
|
|
|
|
 |
D.K.Sethi,
A.Agarwal,
V.Manivel,
K.V.Rao,
and
D.M.Salunke
(2006).
Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response.
|
| |
Immunity,
24,
429-438.
|
 |
|
|
|
|
 |
L.Otte,
T.Knaute,
J.Schneider-Mergener,
and
A.Kramer
(2006).
Molecular basis for the binding polyspecificity of an anti-cholera toxin peptide 3 monoclonal antibody.
|
| |
J Mol Recognit,
19,
49-59.
|
 |
|
|
|
|
 |
V.Moreau,
C.Granier,
S.Villard,
D.Laune,
and
F.Molina
(2006).
Discontinuous epitope prediction based on mimotope analysis.
|
| |
Bioinformatics,
22,
1088-1095.
|
 |
|
|
|
|
 |
H.Xu,
C.M.Weeks,
and
H.A.Hauptman
(2005).
Optimizing statistical Shake-and-Bake for Se-atom substructure determination.
|
| |
Acta Crystallogr D Biol Crystallogr,
61,
976-981.
|
 |
|
|
|
|
 |
M.Urquiza,
R.Lopez,
H.Patiño,
J.E.Rosas,
and
M.E.Patarroyo
(2005).
Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells.
|
| |
J Biol Chem,
280,
35598-35605.
|
 |
|
|
|
|
 |
V.N.Uversky,
C.J.Oldfield,
and
A.K.Dunker
(2005).
Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling.
|
| |
J Mol Recognit,
18,
343-384.
|
 |
|
|
|
|
 |
A.L.Notkins
(2004).
Polyreactivity of antibody molecules.
|
| |
Trends Immunol,
25,
174-179.
|
 |
|
|
|
|
 |
Z.H.Zhou,
and
A.L.Notkins
(2004).
Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.
|
| |
Clin Exp Immunol,
137,
88.
|
 |
|
|
|
|
 |
J.F.Conway,
N.R.Watts,
D.M.Belnap,
N.Cheng,
S.J.Stahl,
P.T.Wingfield,
and
A.C.Steven
(2003).
Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding.
|
| |
J Virol,
77,
6466-6473.
|
 |
|
|
|
|
 |
K.Welfle,
R.Misselwitz,
W.Höhne,
and
H.Welfle
(2003).
Interaction of epitope-related and -unrelated peptides with anti-p24 (HIV-1) monoclonal antibody CB4-1 and its Fab fragment.
|
| |
J Mol Recognit,
16,
54-62.
|
 |
|
|
|
|
 |
L.Lu,
M.E.Lamm,
H.Li,
B.Corthesy,
and
J.R.Zhang
(2003).
The human polymeric immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4.
|
| |
J Biol Chem,
278,
48178-48187.
|
 |
|
|
|
|
 |
A.Heifetz,
E.Katchalski-Katzir,
and
M.Eisenstein
(2002).
Electrostatics in protein-protein docking.
|
| |
Protein Sci,
11,
571-587.
|
 |
|
|
|
|
 |
J.J.Marchalonis,
I.Jensen,
and
S.F.Schluter
(2002).
Structural, antigenic and evolutionary analyses of immunoglobulins and T cell receptors.
|
| |
J Mol Recognit,
15,
260-271.
|
 |
|
|
|
|
 |
D.Jain,
K.J.Kaur,
and
D.M.Salunke
(2001).
Plasticity in protein-peptide recognition: crystal structures of two different peptides bound to concanavalin A.
|
| |
Biophys J,
80,
2912-2921.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.J.Marchalonis,
M.K.Adelman,
I.F.Robey,
S.F.Schluter,
and
A.B.Edmundson
(2001).
Exquisite specificity and peptide epitope recognition promiscuity, properties shared by antibodies from sharks to humans.
|
| |
J Mol Recognit,
14,
110-121.
|
 |
|
|
|
|
 |
T.A.Pitcovsky,
J.Mucci,
P.Alvarez,
M.S.Leguizamón,
O.Burrone,
P.M.Alzari,
and
O.Campetella
(2001).
Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.
|
| |
Infect Immun,
69,
1869-1875.
|
 |
|
|
|
|
 |
E.O.Hochleitner,
C.Borchers,
C.Parker,
R.J.Bienstock,
and
K.B.Tomer
(2000).
Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis.
|
| |
Protein Sci,
9,
487-496.
|
 |
|
|
|
|
 |
F.Fogolari,
R.Ugolini,
H.Molinari,
P.Viglino,
and
G.Esposito
(2000).
Simulation of electrostatic effects in Fab-antigen complex formation.
|
| |
Eur J Biochem,
267,
4861-4869.
|
 |
|
|
|
|
 |
L.J.Holt,
K.Büssow,
G.Walter,
and
I.M.Tomlinson
(2000).
By-passing selection: direct screening for antibody-antigen interactions using protein arrays.
|
| |
Nucleic Acids Res,
28,
E72.
|
 |
|
|
|
|
 |
U.Hoffmüller,
T.Knaute,
M.Hahn,
W.Höhne,
J.Schneider-Mergener,
and
A.Kramer
(2000).
Evolutionary transition pathways for changing peptide ligand specificity and structure.
|
| |
EMBO J,
19,
4866-4874.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Natkunam,
R.V.Rouse,
S.Zhu,
C.Fisher,
and
M.van De Rijn
(2000).
Immunoblot analysis of CD34 expression in histologically diverse neoplasms.
|
| |
Am J Pathol,
156,
21-27.
|
 |
|
|
|
|
 |
C.P.Swaminathan,
A.Nandi,
S.S.Visweswariah,
and
A.Surolia
(1999).
Thermodynamic analyses reveal role of water release in epitope recognition by a monoclonal antibody against the human guanylyl cyclase C receptor.
|
| |
J Biol Chem,
274,
31272-31278.
|
 |
|
|
|
|
 |
C.Pinilla,
R.Martin,
B.Gran,
J.R.Appel,
C.Boggiano,
D.B.Wilson,
and
R.A.Houghten
(1999).
Exploring immunological specificity using synthetic peptide combinatorial libraries.
|
| |
Curr Opin Immunol,
11,
193-202.
|
 |
|
|
|
|
 |
V.Böttger,
L.Peters,
and
B.Micheel
(1999).
Identification of peptide mimotopes for the fluorescein hapten binding of monoclonal antibody B13-DE1.
|
| |
J Mol Recognit,
12,
191-197.
|
 |
|
|
|
|
 |
G.Mazza,
D.Housset,
C.Piras,
C.Gregoire,
S.Y.Lin,
J.C.Fontecilla-Camps,
and
B.Malissen
(1998).
Glimpses at the recognition of peptide/MHC complexes by T-cell antigen receptors.
|
| |
Immunol Rev,
163,
187-196.
|
 |
|
|
|
|
 |
A.Kramer,
T.Keitel,
K.Winkler,
W.Stöcklein,
W.Höhne,
and
J.Schneider-Mergener
(1997).
Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody.
|
| |
Cell,
91,
799-809.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |
|